Search results for: "Novo Nordisk"

(167 records)

Fluor to design and build $2bn API production facility for Novo Nordisk

The global healthcare company will use the facility in North Carolina to produce active pharmaceutical ingredients for diabetes drugs
Ingredients
Ablynx acheives first milestone as part of collaboration with Novo Nordisk

Ablynx acheives first milestone as part of collaboration with Novo Nordisk

Multi-specific nanobody candidate reaches discovery milestone

Effect of insulin on cell growth and virus production

Improving influenza and adenovirus yield with the addition of insulin for vaccine production
Drug Delivery
High-purity quaternary ammonium compounds (Quats)

High-purity quaternary ammonium compounds (Quats)

Visit Novo Nordisk Pharmatech, booth 5B1 at CPHI Worldwide
Design & Build
Novo Nordisk to invest more than €100m in production plants in Chartres, France

Novo Nordisk to invest more than €100m in production plants in Chartres, France

Further strengthening Chartres’ position in the Danish firm's global product supply organisation

Ablynx to work with Novo Nordisk on nanobody drug discovery

Will receive a €5m upfront payment, research funding and potential future milestones and royalties on net sales
Manufacturing
Novo Nordisk to run all production plants on renewable power by 2020

Novo Nordisk to run all production plants on renewable power by 2020

Sets a target of zero carbon emissions from electricity at all global sites in five years

Novo Nordisk invests DKK2.1bn in new insulin filling facility in Denmark

The facility will produce medicines for the treatment of diabetes and obesity and 450 new jobs will be created

Novo Nordisk and University of Washington to explore brain's role in regulating blood sugar and obesity

And develop new treatments for diabetes and obesity
Ingredients
CPhI: Delivering excellence at every step

CPhI: Delivering excellence at every step

On 1 September 2015, FeF Chemicals changed its name to Novo Nordisk Pharmatech
Design & Build
Novo Nordisk to build a manufacturing plant in Iran

Novo Nordisk to build a manufacturing plant in Iran

Signs memorandum of understanding with the Food and Drug Administration of the Islamic Republic of Iran

Novo Nordisk builds new raw material warehouse in Denmark

New 17,000-pallet facility will handle all the company’s inbound raw materials in the country

Novo Nordisk to acquire Calibrium and MB2

Acquisition expands Novo Nordisk’s portfolio of diabetes and obesity projects
Design & Build
Novo Nordisk plans US$2bn investment in new production facilities in US and Denmark

Novo Nordisk plans US$2bn investment in new production facilities in US and Denmark

To produce APIs for oral semaglutide plus other insulin products and handle tableting and packaging

Novo Nordisk pays US$2m for access to Genmab technology

Two Danish firms will develop bispecific antibodies not related to cancer
Brian Hilberdink promoted to President of Novo Nordisk Canada

Brian Hilberdink promoted to President of Novo Nordisk Canada

He has been with the Denmark-headquartered insulin specialist for 20 years

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. Bausch and Lomb hit with FDA Warning Letter for persistent microbial contamination The regulator cited persistent out-of-limit microbial recoveries in ISO 5 areas, deficiencies in aseptic processing and airflow controls and an ineffective quality system at Bausch and Lomb's Tampa manufacturing facility
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Japanese researchers report advances in liver disease treatment and cancer screening Two research teams in Japan have published findings that could open new avenues in metabolic disease treatment and non-invasive cancer screening
  4. FDA approves Telix’s first FET-PET imaging drug for glioma Telix’s Pixclara is the first FDA-approved FET-PET imaging agent for glioma, enabling US clinicians to distinguish recurrent or progressive brain tumours from treatment-related changes
  5. Exceptional excipients enabled with expertise Growing regulatory expectations, increasing pressure to secure resilient regional supply chains and the need for more efficient manufacturing are reshaping how medicines are developed and produced

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing The platform supports pharmaceutical companies in developing, evaluating and optimising formulations and processes for continuous manufacturing
DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

Read more
Manufacturing Enzene is a CIDMO partner supporting innovators and biosimilar developers from discovery to commercial supply with integrated, paradigm-changing biologics services and...
Enzene: Bringing the most advanced innovations to biologics manufacturing

Enzene: Bringing the most advanced innovations to biologics manufacturing

Read more
Research & Development The collaboration combines human-relevant in vitro immunology with in vivo pharmacology to support biotech drug discovery programmes, including endometriosis research
Oncodesign Services and Nexus BioQuest partner on preclinical drug development

Oncodesign Services and Nexus BioQuest partner on preclinical drug development

Read more
Manufacturing UK CDMO Upperton can now manufacture sterile investigational medicinal products at its new 7,000 sq ft facility in Nottingham, expanding its GMP clinical supply capabilities
Upperton gains MHRA licence for Annex 1-aligned sterile facility

Upperton gains MHRA licence for Annex 1-aligned sterile facility

Read more
Pharma 5.0 The next phase of AI adoption in pharma could be less about discovering new medicines and more about tackling the operational barriers that prevent AI projects from scaling,...
Beyond drug discovery: the untapped value of AI in pharma operations

Beyond drug discovery: the untapped value of AI in pharma operations

Read more
Manufacturing As demand for HPAPIs and highly potent drug products grows, the pharmaceutical industry faces increasing pressure to combine containment, product and operator protection,...
Beyond containment: integrated line design reduces risk and complexity

Beyond containment: integrated line design reduces risk and complexity

Read more
Manufacturing Free in-person workshop combines expert theory with hands-on laboratory sessions to build confidence in viscosity measurement
Anton Paar’s popular viscosity workshop returns to Luton this October

Anton Paar’s popular viscosity workshop returns to Luton this October

Read more
Manufacturing New spray drying, dry granulation and pharmaceutical development solutions showcased at CPHI Milan
Glatt presents integrated particle engineering solutions at CPHI Milan

Glatt presents integrated particle engineering solutions at CPHI Milan

Read more